Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study …
… trial programmes on DPP4 inhibitors include limited number of patients from India. Key opinion leaders in diabetic segment of India have identified the need for study on Indian patients …..... Read More